Phase 1b Trial of BGJ398/BYL719 in Solid Tumors

NCT01928459 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

62

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors
Metastatic Solid Tumors

Interventions

DRUG: BGJ398
DRUG: BYL719

Sponsor

Novartis Pharmaceuticals